Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
miR-30 Family Dysregulation in Schizophrenia
NCT02650102Phase 2Unknown
- Sponsor
- Shanxi Medical University
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone in schizophrenia, sponsored by Shanxi Medical University. Status: unknown.
02
Drugs
risperidoneolanzapinequetiapinearipiprazoleziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02650102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02650102.